SLS Latest Headlines

SELLAS Edges Closer to Pivotal Phase 3 Data with Strong Cash Position and Multiple Upcoming Catalysts

Market Chameleon (Wed, 13-May 10:34 AM)

SELLAS Nears Key Phase 3 Milestone as Pipeline Advances and Cash Reserves Strengthen

Market Chameleon (Wed, 13-May 7:07 AM)

SELLAS Life Sciences Strengthens Cash Reserves and Expands Clinical Pipeline Amid Pivotal 2026 Milestones

Market Chameleon (Fri, 20-Mar 10:05 AM)

SLS009 Shows Potent Activity Against High-Risk AML in Preclinical Data—Broad Efficacy Across Challenging Genetic Subtypes

Market Chameleon (Wed, 18-Mar 7:31 AM)

Enrollment Milestone for SLS009: Phase 2 AML Trial Targets Patients Least Likely to Respond to Standard Therapy

Market Chameleon (Thu, 12-Mar 9:25 AM)